| (1) |
| (a) | Subject to Subsections (1)(b) through (f), an individual licensed as a psychologist may engage in all acts and practices defined as the practice of psychology without supervision, in private and independent practice, or as an employee of another person, limited only by the licensee's education, training, and competence. |
| (b) | Only a certified prescribing psychologist or provisional prescribing psychologist may prescribe, administer, and discontinue selective serotonin reuptake inhibitors, and other medications approved under Subsection (1)(c), recognized in or customarily used in the diagnosis, treatment, and management of individuals with psychiatric, mental, cognitive, nervous, emotional, developmental, or behavioral disorders, including:
| (ii) | diagnostic examinations; and |
| (iii) | procedures that are:
| (A) | necessary to obtain laboratory tests or diagnostic examinations; |
| (B) | relevant to the practice of psychology; and |
| (C) | in accordance with division rule made in consultation with the board. |
|
|
| (c) |
| (i) | The division may, by rule made in consultation with the Physicians Licensing Board created in Section 58-67-201, approve medications other than selective serotonin reuptake inhibitors for prescribing by certified prescribing psychologists or provisional prescribing psychologists.
(ii) If the division approves a medication under Subsection (1)(c)(i), the division shall notify the Health and Human Services Interim Committee of the approval within 14 days after the day on which the medication is approved. |
|
| (d) |
| (i) | A certified prescribing psychologist may only prescribe psychotropic medication for a patient if the certified prescribing psychologist:
| (A) | identifies a health care practitioner currently overseeing the patient's general medical care; and |
| (B) | establishes and maintains a collaborative relationship with that health care practitioner. |
|
| (ii) | When prescribing a psychotropic medication for a patient, a certified prescribing psychologist shall establish and maintain a collaborative relationship with a health care practitioner who oversees the patient's general medical care to ensure that:
| (A) | necessary medical examinations are conducted; |
| (B) | the psychotropic medication is appropriate for the patient's medical condition; and |
| (C) | significant changes in the patient's medical or psychological conditions are discussed. |
|
| (iii) | A health care practitioner under Subsections (1)(c)(i) and (ii) shall be:
| (A) | a physician licensed under Chapter 67, Utah Medical Practice Act, or Chapter 68, Utah Osteopathic Medical Practice Act; or |
| (B) | a psychiatric mental health nurse practitioner, as defined in Section 58-1-111. |
|
|
| (e) | A certified prescribing psychologist and provisional prescribing psychologist may not prescribe or administer:
| (ii) | controlled substances. |
|
| (f) | The division, in consultation with the board and the Physicians Licensing Board created in Section 58-67-201, may make rules further defining this section's limitations relating to prescribing psychology, allowable medications, and collaborative relationship requirements. |
|
